Article: King Pharmaceuticals Reports FDA Acceptance of Altace(R) Supplemental New Drug Application for Delaying the Progression of Chronic Kidney Disease in Hypertensive, Non-Diabetic Patients.

Article: King Pharmaceuticals Announces Completion of Patient Enrollment ...
PR Newswire;  November 3, 2003 ;     700+ words ... ... dosage and administration of Altace(R) for the treatment of ... Modernization Act of 1997, Altace(R) should receive an additional ... children is commonly caused by kidney disease, certain heart diseases and ... damage to the eyes. About Altace(R) Altace(R) is marketed ...

Article: FDA accepts King Pharma's sNDA for Altace.(Food and Drug ...
Pharma Marketletter;  October 3, 2005 ;     700+ words ... ... indication for Altace as initial ... of chronic kidney disease in hypertensive ... American Study of Kidney Disease and Hypertension ... efficacy of Altace and two other ... the effect of Altace on the progression of kidney disease as measured ...

Article: Altace still best for Type 1 diabetics
The Milwaukee Journal Sentinel;  December 10, 2001 ;     660 words ... ... As a type 1 diabetic on Altace 2.5mg every day, I am wondering ... inhibitors, such as the Altace that you are taking. Spilling ... earliest marker for diabetic kidney disease. An analysis of 10 major studies ... that you should stick with the Altace for now. Q. Help, I am at ...

Article: King Pharmaceuticals Reports Favorable Altace(R) Trial ...
PR Newswire;  November 21, 2002 ;     700+ words ... ... of the African American Study of Kidney Disease and Hypertension ("AASK") related to King's largest product Altace(R) (ramipril), an angiotensin ... the Progression of Hypertensive Kidney Disease CHICAGO -- Lowering blood pressure ...

Article: King Pharmaceuticals Reports Efficacy of ALTACE(R) 20mg ...
Business Wire;  May 19, 2007 ;     700+ words ... ... its Phase III clinical trial evaluating ALTACE([R]) (ramipril) 20mg and the combination of ALTACE 20mg and hydrochlorothiazide (HCT) 25mg ... Illinois. The clinical trial data showed that ALTACE 20mg resulted in significant reductions ...

Article: King Pharmaceuticals Announces Jack Nicklaus As Spokesperson For ...
PR Newswire;  October 29, 2001 ;     700+ words ... ... as a spokesperson for King's product Altace(R) (ramipril), an angiotensin converting enzyme ("ACE") inhibitor. Altace(R) is marketed by Monarch Pharmaceuticals ... cgi-bin/prnh/20010125/KGLOGO ) Altace(R) was first approved by the U.S ...

Article: Recently Reported ALLHAT Trial Does Not Address Benefits of ...
PR Newswire;  December 19, 2002 ;     700+ words ... ... converting enzyme ("ACE") inhibitor, Altace(R) (ramipril), was not included ... examined, in part, the effects of Altace(R) in reducing cardiovascular events ... cardiovascular events in patients taking Altace(R) reported from the HOPE trial include ...